Playing a wind instrument could prove fatal, medics have warned, after a man died from a lung disease triggered by harmful bacteria in his bagpipes.
A report in the journal Thorax describes a newly recognised cause of the potentially fatal lung disease hypersensitivity pneumonitis - playing a contaminated wind instrument.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
While the trigger for his illness was initially a mystery, reports The Guardian, a series of clues led doctors to discover the cause was most likely a collection of six species of toxic fungi living inside the man’s bagpipes – something the report authors have named "bagpipe lung".
The damage from hypersensitivity pneumonitis occurs when the body's immune system goes into overdrive, says the BBC. The inhaled pathogens trigger inflammation that left unchecked causes progressive and irreversible scarring.
"[Musicians] need to be aware that there are risks that instruments can become colonised with mould and fungi and this can be related to serious and potentially fatal lung disease," said Dr Jenny King, of North Manchester general hospital, the lead author of the study.
"There isn't a lot of evidence about the best way to clean these instruments", King added. "What’s described in the literature is taking the instrument apart piece by piece, cleaning it with disinfectant and allowing it to drip dry."
Kevin Lamb, the chairman of the Windband Association, told the BBC all instruments were cleanable and members were directed to information on how to clean their instrument when joining the association.
The case has led doctors to propose bagpipe lung be added to the long list of alternative monikers for hypersensitivity pneumonitis, says the Guardian. The disease is already known as bird fancier's, farmer's and even hot-tub lung after the wide range of activities to which it has previously been linked.
-
Why social media is obsessed with cortisolIn The Spotlight Wellness trend is the latest response to an increasingly maligned hormone
-
Peter Mandelson called Epstein his 'best pal' in birthday noteSpeed Read The UK's ambassador to Washington described the late convicted paedophile as an 'intelligent, sharp-witted man'
-
A Spinal Tap reunion, Thomas Pynchon by way of Paul Thomas Anderson and a harrowing Stephen King adaptation in September moviesthe week recommends This month's new releases include 'Spinal Tap II,' 'One Battle After Another' and 'The Long Walk'
-
How the care industry came to rely on migrant workersThe Explainer Government crackdown on recruiting workers abroad risks deepening care sector crisis, industry leaders warn
-
Could medics' misgivings spell the end of the assisted dying bill?Today's Big Question The Royal College of Psychiatrists has identified 'serious concerns' with the landmark bill – and MPs are taking notice
-
Washwood Heath: Birmingham's pioneering neighbourhood health serviceIn the Spotlight NHS England chair says there is a 'really good argument this is the model for the future'
-
The UK's first legal drug consumption roomThe Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
-
How can the UK solve the adult social care crisis?Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
-
Should blood donors be paid?The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
-
UK gynaecological care crisis: why thousands of women are left in painThe Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
-
A 'transformative' gene therapy for haemophilia BThe Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost
